Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) ("Profound” or the "Company”) is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders that was held today ...

Profound Medical Corp.’s PROF share price has dipped by 5.02%, which has investors questioning if this is right time to buy.

First quarter 2025 net loss was approximately $10.7 million, or $0.36 per common share, compared to approximately $6.6 million, or $0.27 per common share, in the three months ended March 31, 2024. As ...